L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation
Aims: Tay–Sachs and Sandhoff diseases (GM2 gangliosidosis) are autosomal recessive disorders of lysosomal function that cause progressive neurodegeneration in infants and young children. Impaired hydrolysis catalysed by β-hexosaminidase A (HexA) leads to the accumulation of GM2 ganglioside in neuron...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f52039e69fcc4dfe90d6e42e02924715 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f52039e69fcc4dfe90d6e42e02924715 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f52039e69fcc4dfe90d6e42e029247152021-11-25T17:11:45ZL-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation10.3390/cells101131222073-4409https://doaj.org/article/f52039e69fcc4dfe90d6e42e029247152021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3122https://doaj.org/toc/2073-4409Aims: Tay–Sachs and Sandhoff diseases (GM2 gangliosidosis) are autosomal recessive disorders of lysosomal function that cause progressive neurodegeneration in infants and young children. Impaired hydrolysis catalysed by β-hexosaminidase A (HexA) leads to the accumulation of GM2 ganglioside in neuronal lysosomes. Despite the storage phenotype, the role of autophagy and its regulation by mTOR has yet to be explored in the neuropathogenesis. Accordingly, we investigated the effects on autophagy and lysosomal integrity using skin fibroblasts obtained from patients with Tay–Sachs and Sandhoff diseases. Results: Pathological autophagosomes with impaired autophagic flux, an abnormality confirmed by electron microscopy and biochemical studies revealing the accelerated release of mature cathepsins and HexA into the cytosol, indicating increased lysosomal permeability. GM2 fibroblasts showed diminished mTOR signalling with reduced basal mTOR activity. Accordingly, provision of a positive nutrient signal by L-arginine supplementation partially restored mTOR activity and ameliorated the cytopathological abnormalities. Innovation: Our data provide a novel molecular mechanism underlying GM2 gangliosidosis. Impaired autophagy caused by insufficient lysosomal function might represent a new therapeutic target for these diseases. Conclusions: We contend that the expression of autophagy/lysosome/mTOR-associated molecules may prove useful peripheral biomarkers for facile monitoring of treatment of GM2 gangliosidosis and neurodegenerative disorders that affect the lysosomal function and disrupt autophagy.Beatriz Castejón-VegaAlejandro RubioAntonio J. Pérez-PulidoJosé L. QuilesJon D. LaneBeatriz Fernández-DomínguezMaría Begoña Cachón-GonzálezCarmen Martín-RuizAlberto SanzTimothy M. CoxElísabet Alcocer-GómezMario D. CorderoMDPI AGarticleautophagymTORGM2 gangliosidosisL-arginineBiology (General)QH301-705.5ENCells, Vol 10, Iss 3122, p 3122 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
autophagy mTOR GM2 gangliosidosis L-arginine Biology (General) QH301-705.5 |
spellingShingle |
autophagy mTOR GM2 gangliosidosis L-arginine Biology (General) QH301-705.5 Beatriz Castejón-Vega Alejandro Rubio Antonio J. Pérez-Pulido José L. Quiles Jon D. Lane Beatriz Fernández-Domínguez María Begoña Cachón-González Carmen Martín-Ruiz Alberto Sanz Timothy M. Cox Elísabet Alcocer-Gómez Mario D. Cordero L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation |
description |
Aims: Tay–Sachs and Sandhoff diseases (GM2 gangliosidosis) are autosomal recessive disorders of lysosomal function that cause progressive neurodegeneration in infants and young children. Impaired hydrolysis catalysed by β-hexosaminidase A (HexA) leads to the accumulation of GM2 ganglioside in neuronal lysosomes. Despite the storage phenotype, the role of autophagy and its regulation by mTOR has yet to be explored in the neuropathogenesis. Accordingly, we investigated the effects on autophagy and lysosomal integrity using skin fibroblasts obtained from patients with Tay–Sachs and Sandhoff diseases. Results: Pathological autophagosomes with impaired autophagic flux, an abnormality confirmed by electron microscopy and biochemical studies revealing the accelerated release of mature cathepsins and HexA into the cytosol, indicating increased lysosomal permeability. GM2 fibroblasts showed diminished mTOR signalling with reduced basal mTOR activity. Accordingly, provision of a positive nutrient signal by L-arginine supplementation partially restored mTOR activity and ameliorated the cytopathological abnormalities. Innovation: Our data provide a novel molecular mechanism underlying GM2 gangliosidosis. Impaired autophagy caused by insufficient lysosomal function might represent a new therapeutic target for these diseases. Conclusions: We contend that the expression of autophagy/lysosome/mTOR-associated molecules may prove useful peripheral biomarkers for facile monitoring of treatment of GM2 gangliosidosis and neurodegenerative disorders that affect the lysosomal function and disrupt autophagy. |
format |
article |
author |
Beatriz Castejón-Vega Alejandro Rubio Antonio J. Pérez-Pulido José L. Quiles Jon D. Lane Beatriz Fernández-Domínguez María Begoña Cachón-González Carmen Martín-Ruiz Alberto Sanz Timothy M. Cox Elísabet Alcocer-Gómez Mario D. Cordero |
author_facet |
Beatriz Castejón-Vega Alejandro Rubio Antonio J. Pérez-Pulido José L. Quiles Jon D. Lane Beatriz Fernández-Domínguez María Begoña Cachón-González Carmen Martín-Ruiz Alberto Sanz Timothy M. Cox Elísabet Alcocer-Gómez Mario D. Cordero |
author_sort |
Beatriz Castejón-Vega |
title |
L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation |
title_short |
L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation |
title_full |
L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation |
title_fullStr |
L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation |
title_full_unstemmed |
L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation |
title_sort |
l-arginine ameliorates defective autophagy in gm2 gangliosidoses by mtor modulation |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/f52039e69fcc4dfe90d6e42e02924715 |
work_keys_str_mv |
AT beatrizcastejonvega larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT alejandrorubio larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT antoniojperezpulido larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT joselquiles larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT jondlane larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT beatrizfernandezdominguez larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT mariabegonacachongonzalez larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT carmenmartinruiz larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT albertosanz larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT timothymcox larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT elisabetalcocergomez larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation AT mariodcordero larginineamelioratesdefectiveautophagyingm2gangliosidosesbymtormodulation |
_version_ |
1718412688866934784 |